Indeed, a Mendelian randomization analysis showed a positive association between genetically predicted fasting insulin with breast cancer risk and suggest that genetically determined obesity and insulin-related traits play an important role in the etiology of breast cancer15. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.